GlassScriptPhysician profile
Morgan Barr
NPI 1114462827
$5,257.49
in general payments reported to CMS, 2019-2025
24 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.65 · 2020: $51.90 · 2021: $86.55 · 2022: $129 · 2023: $144 · 2024: $4,493 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,016 · Travel and Lodging: $1,113 · Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,015.89 |
| Travel and Lodging | $1,112.61 |
| Food and Beverage | $845.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,274.51 | 2023-2025 | Da Vinci Surgical System |
| Sumitomo Pharma America, INC. | $167.26 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $136.29 | 2024-2025 | Veozah |
| Abbvie INC. | $95.29 | 2022-2024 | Lo Loestrin Fe |
| Organon LLC | $79.22 | 2021-2025 | Nexplanon, Jada System |
| Biogen, INC. | $71.10 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $55.08 | 2021-2025 | Injectafer |
| Meditrina | $47.72 | 2021 | |
| Lupin INC. | $41.53 | 2019-2021 | |
| Evofem Biosciences, INC. | $29.46 | 2022 | |
| Glaxosmithkline, LLC. | $27.18 | 2023 | Nucala |
| Bayer Healthcare Pharmaceuticals INC. | $23.10 | 2020 | |
| Coopersurgical, INC. | $22.63 | 2024 | Paragard T 380a |
| Genentech USA, INC. | $22.34 | 2024 | Evrysdi |
| Hologic Sales and Service, LLC | $21.49 | 2025 | Novasure, Myosure Tissue Removal Device |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $18.17 | 2022 | |
| Ethicon US, LLC | $17.82 | 2024 | Surgicel Nu-Knit, Vistaseal |
| Millicent US INC | $17.60 | 2025 | Intrarosa |
| Aroa Biosurgery Incorporated | $17.40 | 2025 | |
| Sage Therapeutics, LLC | $15.18 | 2023 | |
| Mayne Pharma Commercial LLC | $15.04 | 2022 | |
| Merck Sharp & Dohme LLC | $14.42 | 2020 | |
| Minerva Surgical, INC | $14.38 | 2025 | |
| Pfizer INC. | $13.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Barr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.